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In the epidermis, b1 integrin expression is normally
confined to the basal layer; however, suprabasal expres-
sion of b1 integrins in keratinocytes has been found in
psoriasis, and it has been suggested that it could be a
pathogenic factor of the disease. We have investigated
herein the functional state of b1 integrins of human
keratinocytes in normal skin and psoriasis. The expression
of b1-activation-reporter epitopes was monitored with
two monoclonal antibodies, HUTS-21 and MG5A7, that
recognize epitopes whose expression parallels functional
activity of b1 integrins and correlates with the ligand
binding activity of these heterodimeric glycoproteins.
We have found that keratinocytes express activation
epitopes of b1 integrins, and that these epitopes can be
In the epidermis, β1 integrin expression is normally confinedto the basal layer; however, there are several situations in whichsuprabasal, differentiating keratinocytes express β1 integrins.This has been described during wound healing (Hertle et al,1992; Jones et al, 1993), and in several cutaneous diseases,
including psoriasis (Horrocks et al, 1991; Ralfkiaer et al, 1991; Hertle
et al, 1992; Pellegrini et al, 1992; Giannelli et al, 1994), eczema, and
lichen planus (Ralfkiaer et al, 1991).
Human keratinocytes express several β1 integrins that include: α2β1,
a collagen receptor; α3β1, a laminin and collagen receptor; and α5β1,
a receptor for fibronectin (Guo et al, 1991; Watt and Hertle, 1994).
In keratinocytes, β1 integrins not only mediate cell adhesion and
migration, but also regulate stratification and the initiation of terminal
differentiation (Watt and Hertle, 1994), and it is a marker of stem cells
(Jones and Watt, 1993). It has been shown that suprabasal integrin
expression is not a direct consequence of inflammation because it is
not induced by intradermal injections of cytokines (Hertle et al, 1995),
and it has been suggested that suprabasal expression of integrins could
be a pathogenic factor in psoriasis (Carroll et al, 1995).
Integrin function is regulated at two different levels: selective
expression (Guo et al, 1991; Kim et al, 1992) and modulation of its
binding properties (Schwartz et al, 1995; Sa´nchez-Mateos et al, 1996).
Although most studies have focused on the regulation of expression,
recently new antibodies that recognize the activated state of integrins
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modulated by manganese. The expression of activation
epitopes of b1 integrins was related to an enhanced
adhesion to fibronectin and collagen. Immunohisto-
chemical studies of normal and psoriatic skin with
HUTS-21 and other monoclonal antibodies indicate
that, although there is suprabasal expression of b1
integrins in psoriasis, these molecules seem to be in an
inactive state. Moreover, most b1 integrins in lateral and
apical surfaces of basal keratinocytes of psoriasis are
also in a nonactive conformation, implying a decrease
of activity compared with normal skin, in which active
b1 integrins are distributed all over the basal keratino-
cytes. Key words: activation-dependent epitope/HUTS-21/
keratinocyte. J Invest Dermatol 111:19–24, 1998
allow the study of the modulation of their binding properties (Lenter
et al, 1993; Miyake et al, 1994; Bazzoni et al, 1995; Mould et al, 1995;
Yednock et al, 1995). For the β1 family the monoclonal antibody
(MoAb) HUTS-21 has been generated and characterized. The epitope
recognized by this MoAb is contained within the sequence 355–425
of the β1 chain. Its expression parallels functional activity of VLA
integrins and correlates with the ligand binding activity of these
heterodimeric glycoproteins (Luque et al, 1996).
In order to assess the functional state of human keratinocytes in
normal and diseased skin, we have studied herein the expression and
regulation of β1 activation-reporter epitopes in cultured keratinocytes
in normal skin and psoriasis.
MATERIALS AND METHODS
Keratinocytes Normal human keratinocytes (NHK) were cultured, with few
modifications, as previously described (Jones and Watt, 1993; Parenteau, 1994).
In brief, epidermal strips were isolated from the skin of cosmetic surgery using
1.2 U dispase per ml (Boehringer, Mannheim, Germany) for 24 h at 4°C.
After incubation of epidermal strips in 0.05% trypsin/0.02% ethylenediamine
tetraacetic acid for 25 min at room temperature, keratinocytes were seeded
onto plastic dishes at 40,000 cells per cm2. The culture medium consisted of
one part Ham’s F-12 medium and three parts Dulbecco’s modification of Eagle’s
medium (DMEM, GIBCO, Scotland) supplemented with 10% fetal calf serum,
1.8 3 10–4 M adenine (Sigma, St. Louis, MO), 0.5 µg hydrocortisone per ml
(Sigma), 5 µg insulin per ml (Boehringer), 10 ng epidermal growth factor per
ml (ICN Biochemicals, Irvine, CA), 5 µg transferrin per ml (Sigma), and 10 ng
cholera toxin per ml (ICN Biochemicals). The medium was replaced every
other day and cells were passed when almost confluent. Cultures were used
between the first and fourth passages.
Antibodies MoAb used in this study directed to the common β1 integrin
chain have previously been described: the activating TS2/16 (CD 29) (Hemler
et al, 1984), the activation-reporter HUTS-21 (Luque et al, 1996), and the
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adhesion-blocking Lia1/2 and VJ1/14 (Campanero et al, 1992). MG5A7 is a
new anti-β1 MoAb generated by immunizing mice with human umbilical vein
endothelial cells, which recognizes an epitope on β1 integrins that appears upon
activation of β1 integrins with different stimulatory agents, like Mn21 cations.
The P3X63 mouse myeloma protein (IgG1, kappa) was used as negative control.
The HP2/9 anti-CD44 MoAb has been previously described (de la Hera
et al, 1989).
Flow cytometry Keratinocytes were detached with 0.05% trypsin and 0.02%
ethylenediamine tetraacetic acid, counted, and aliquoted into separate tubes
(100,000 cells per tube). Cells were washed in DMEM or HEPES/NaCl buffer
(20 mM HEPES, 150 mM NaCl, 2 mg D-glucose per ml, pH 7.4) and
resuspended in DMEM or HEPES/NaCl buffer containing the appropriate
concentrations of divalent cations or stimuli. The corresponding MoAb was
added and cells were incubated for 15 min at 37°C. After this incubation, cells
were washed in phosphate buffered saline (PBS) and incubated with 100 µl of
1:100 dilution of fluorescein-isothiocyanate-conjugated sheep anti-mouse IgG
secondary antibody (DAKO) for 20 min at 4°C. Cells were washed and
resuspended in PBS with 10 µg propidium iodide per ml and then analyzed in
a Becton Dickinson FACScan flow cytometer. Cell analysis were gated both
on forward- and size-scatter intensities and propidium iodide fluorescence to
discard dead cells.
Immunofluorescence digital confocal microscopy Keratinocytes were
plated in complete medium on glass coverslips and grown until almost confluent.
Cells were fixed in 3.7% paraformaldehyde in PBS. Coverslips were then
incubated with the primary antibody for 30 min at 37°C, washed, and incubated
with the fluorescein-isothiocyanate-conjugated sheep anti-mouse IgG secondary
antibody (DAKO) at 1:100 for 30 min at 37°C. Specimens were examined
with an MRC 1024 Bio-Rad confocal system (Bio-Rad Richmond, CA)
mounted on a Zeiss Axiovert 135 microscope (Zeiss, Oberkochen, Germany)
equipped with a 363, 1.4 NA planapochromat objective. Images were stored
on magnetoptical disks.
Cell attachment assays Cell adhesion assays were essentially performed as
previously described (Luque et al, 1996). Briefly, 96 well flat-bottomed plates
(Titertek, ICN Biochemicals) were coated with the β1 integrin ligands type 1
collagen (ICN Biochemicals) or fibronectin (Sigma) at the indicated concentra-
tions by overnight incubation at 4°C. After saturation of free plastic sites of
wells with 1% boiled bovine serum albumin in PBS for 1 h at room temperature,
plates were washed three times with PBS and once with 200 µl of HEPES/
NaCl buffer. Fifty microliters of HEPES/NaCl buffer containing 2.5 µg of
purified MoAb and/or 2 mM MnCl2 were then added to the wells; 2.5 3 10
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keratinocytes in 50 µl of HEPES/NaCl buffer were added to each well and
allowed to sediment onto the bottom of the wells for 10 min at 4°C. Plates
were then transferred to a CO2 incubator and incubated for 30 min at 37°C.
The percentage of cells that remained adhered after three gentle washes of the
wells with 200 µl of warm HEPES/NaCl buffer was calculated by measuring
the absorbency of the wells at 540 nm after fixation and staining with 0.5%
crystal violet in 20% methanol.
Immunohistochemistry of cutaneous biopsies Eight patients with
psoriasis were involved in the study after obtaining an informed consent
approved by the Ethical Committee of the Hospital Universitario de la Princesa.
Normal skin from excisional surgery from six patients served as controls. A
biopsy specimen was obtained from representative areas on extremities under
local anesthesia with 2% mepivacaine hydrochloride. All biopsy specimens were
snap frozen embedded in OCT (Miles, Naperville, IL) in liquid nitrogen and
serially sectioned using a rotary cryostat microtome. Cryostat-cut unfixed
sections were mounted on glass slides, covered with acetone for 10 min, dried
at room temperature and stored at –70°C.
Immunohistochemical staining of psoriatic and normal skin was performed
in parallel on frozen sections using a two-step immunoperoxidase technique as
described (Ferna´ndez-Herrera et al, 1989). The sections were incubated in a
humidity chamber with the primary monoclonal antibody for 45 min. Slides
were rinsed in 1 M Tris-HCl buffer pH 7.6, for 10 min and then covered
with rabbit-anti-mouse immunoglobulin conjugated to horseradish peroxidase
(DAKO). After two washes in Tris buffer, enzyme staining was developed for
10 min with diaminobenzidine and H2O2. The staining reaction was stopped
by washing the slides in Tris buffer. Finally, they were counterstained with
hematoxylin for 1 min, rinsed in tap water, dehydrated, and mounted.
Sections of skin and keratinocytes in culture were examined by two
independent observers. The extent and intensity of staining for each MoAb
were recorded and photographs were taken.
RESULTS
Expression of activation-reporter epitopes of β1 integrin in
keratinocytes We explored whether the expression of the activation-
Figure 1. Influence of manganese on the expression of activation
epitopes of b1 integrins in NHK. (a) Flow cytometry profiles of the
influence of Mn21 10 mM in the expression of HUTS-21. (b) Expression of
activation epitopes HUTS-21 and MG5A7 correlated to the concentration
of Mn21 in the assay medium. NHK were resuspended in DMEM containing
the appropriate concentrations of Mn21. The corresponding MoAb was added
and cells were incubated at 37°C. The data are given as the percentage of
fluorescence intensity with respect to basal expression. Each point is the mean
6 SEM. The number of experiments is given in parentheses.
dependent conformational epitopes of β1 were regulated in NHK.
The expression of β1 was monitored by using TS2/16 and Lia1/2
MoAb, which recognize constitutively expressed epitopes, and HUTS-
21 and MG5A7 MoAb, specific for activation-related epitopes. When
NHK were incubated at 4°C, the activation β1 epitopes were not
detected, whereas a high expression of TS2/16 and Lia1/2 epitopes
was observed. Incubation at 37°C showed a significant expression of
the activation β1 epitopes, whereas TS2/16 and Lia1/2 expression was
not altered. Furthermore, the expression of β1-activation epitopes was
also determined on keratinocytes under conditions of divalent cations
described to change β1 integrins to a high affinity state. Mn21 has
been described as one of the most important activating cations of β1
integrins (Luque et al, 1996). We found an enhanced expression of the
activation epitopes detected by HUTS-21 and MG5A7 (Fig 1a). The
induced expression of the activation epitopes correlated with the
concentration of Mn21 used (Fig 1b).
Although Mn21 has been described to enhance adhesion of T
lymphoblasts to fibronectin and type I collagen (Luque et al, 1996),
we performed adhesion studies to explore if the increased expression
of HUTS-21 induced by Mn21 was correlated by changes in the
adhesion of keratinocytes through β1 integrins (Fig 2). We found that
both TS2/16 and Mn21 greatly enhance the adhesion of NHK to
fibronectin (0.5–1 µg per ml) and type I collagen (0.25–0.5 µg per
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Figure 2. Manganese stimulates the adhesion of keratinocytes to
fibronectin and type I collagen through b1 integrins. The dependency of
this adhesion on VLA integrin function is demonstrated by the blockade with
the inhibitory anti-β1 MoAb VJ1/14. Incubation with the activating anti-β1
TS2/16 MoAb was used as a positive control. Control with lymphoblasts was
carried out in parallel (data not shown). NHK were seeded onto plastic wells
coated with fibronectin at 0.5 µg per ml and type I collagen at 0.25 µg per ml
containing 2.5 µg of purified MoAb and/or 2 mM MnCl2. One representative
experiment performed in triplicate is shown. The data are given as the percentage
of absorbency with respect to control.
ml). We also found that the MoAb VJ1/14, a very potent inhibitory anti-
β1 MoAb, almost reversed the enhanced adhesion induced by Mn21.
Localization of activated β1 integrins on cultured keratino-
cytes Immunofluorescence digital confocal microscopy studies of
cultured NHK showed different patterns of expression with the anti-
β1 antibodies studied. Both TS2/16 and Lia1/2 showed fluorescence
in all four optical sections taken at a pitch of 0.5 µm indicating
expression all over the cell membrane, with an enhancement of the
fluorescence in the intercellular surfaces (Fig 3a–d).
In contrast, activated epitopes on β1 integrins assessed by HUTS-
21 and MG5A7 MoAb showed little intercellular staining. Conspicuous
linear arrangement of fluorescence in the basal surface of the cell was
found in most keratinocytes with both antibodies (Fig 3e, f ). No
staining was found in other optical sections of the cell above the basal
surface. The negative control P3X63 did not show any relevant staining.
Expression of activated b1 integrins in normal skin and
psoriasis We found that in normal skin, β1 integrins, evaluated by
TS2/16 and Lia1/2, were present only in the basal cell layer of
keratinocytes, and these cells were stained throughout the cell with
conspicuous staining in the membrane (Fig 4a, b). Dermal endothelium
showed a strong reactivity similar to the basal cell layer.
HUTS 21 and MG5A7 antibodies stained only the basal cell layer
of normal skin, and keratinocytes were stained all over the cell, both
at the membrane and at the cytoplasm (Figs 4c, d, 5a, b). Capillaries
and other endothelia showed similar staining to that found on the
epidermis.
In psoriatic skin, there was a strong expression of β1 integrins in
the basal cell layer, predominantly on the membrane. A consistent
staining could be found in keratinocytes of suprabasal layers with
TS2/16 and Lia1/2 antibodies but only in the tips of dermal papillae
(Fig 4e, f ). The endothelium of capillary vessels showed a similar
staining to that found in the basal cell layer.
Activation β1 epitopes were detected consistently only in the dermo–
epidermal junction, with scant or no staining in the rest of the cell
(Figs 4g, h, 5d, e). Endothelium showed a stronger staining, which
was similar to what we found in normal skin.
As a control for staining intensity we included the CD44 hyaluronate
receptor (Fig 5c, f ). A comparable CD44 staining pattern was found
in both normal and psoriatic skin.
DISCUSSION
Integrins are important molecules in cell–cell and cell–extracellular
matrix interactions and regulate cell functions and behavior in many
Figure 3. Localized expression to the basal surface of the cell of
activation epitopes of b1 integrins in cultured keratinocytes.
Immunofluorescence digital confocal microscopy of cells with TS2/16 (a–d)
and HUTS 21 (e, f). For each field, four optical sections from the cell–matrix
contact area to the top were obtained at a pitch of 0.5 µm. Only the first two
optical sections of HUTS 21 are shown due to the absence of fluorescence in
the others.
cell types (Schwartz et al, 1995). Cellular adhesive properties are
regulated through the selective expression of integrins (Guo et al, 1991)
as well as by the modulation of the binding properties of these
receptors. The avidity of integrins for their ligands is not constant and
is dynamically regulated (Sa´nchez-Mateos et al, 1996). The existence
of different conformations of β1 integrins in vivo has been inferred
from both cell adhesion studies with keratinocytes and the observations
recently described on the expression of activated β1 integrins in vitro
(Kim and Yamada, 1997); however, a direct assessment of the expression
of activated β1 in normal and diseased skin has not been explored so
far. The use of the HUTS-21 and MG5A7 MoAb, which detect
activation-dependent epitopes of β1 integrins (Luque et al, 1996), has
facilitated the study of activated β1 expression both in vivo and in vitro.
These MoAb recognize epitopes on a regulatory region of the common
β1 subunit of VLA integrins whose expression parallels functional
activation and ligand binding by these adhesion receptors (Luque et al,
1996; Go´mez et al, 1997).
We have found that keratinocytes express activation epitopes of β1
integrins, we have shown that these epitopes can be modulated by
manganese, an inducer of adhesion of keratinocytes (Hotchin et al,
1993) and a potent inducer of activation epitopes in β1 integrins
(Luque et al, 1996), and we have shown that these epitopes are related
to adhesion to fibronectin and type I collagen. These data are in
agreement with previous reported observations with T lymphocytes
(Luque et al, 1996). In cultured NHK, our results showed that, whereas
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Figure 4. Different pattern of expression of b1 integrins in normal and psoriatic skin. Immunohistochemical study of the expression in normal skin (a–d)
and psoriasis (e–h) of TS2/16 (a, e), Lia1/2 (b, f), HUTS-21 (c, g), and MG5A7 (d, h). Suprabasal expression of TS2/16 and Lia1/2 is found in psoriasis whereas
HUTS 21 and MG5A7 only stain the dermo–epidermal junction. Scale bar: 50 µm; inserts, 20 µm.
β1 integrins can be found all over the keratinocyte membrane,
activation epitopes appear mainly in a linear arrangement on the basal
surface of cells where focal adhesions are formed (Kim and Yamada,
1997). This distribution could be the reflection of the interactions with
extracellular matrix ligands, similar to what has been described in
human lymphocytes (Sa´nchez-Mateos et al, 1996; Go´mez et al, 1997).
Under physiologic conditions, HUTS-21 detects a ligand induced
binding site epitope on β1 (Go´mez et al, 1997). In addition, stimulating
agents acting from without the cell, such as Mn21 and activating TS2/
16 MoAb, can impose a similar conformation to that induced by ligand
occupancy.
Expression of β1 integrin has been related to the proliferative state
of keratinocytes (Jones and Watt, 1993; Bata-Csorgo et al, 1995).
Parallel to accelerated proliferation, the β1 integrin expression became
very bright in vitro. As the proliferation slowed down on confluent
cultures, the intensity diminished (Bata-Csorgo et al, 1995). Moreover,
β1 integrins are downregulated when keratinocytes initiate terminal
differentiation (Jones and Watt, 1993; Hodivala and Watt, 1994).
Nevertheless, keratinocytes in vitro have a high proliferative rate
(Rheinwald and Green, 1977) similar to psoriatic epidermis, and
express β1 integrins together with several markers of differentiation
(peanut agglutinin, involucrin, K1/K10 keratins) (Hodivala and Watt,
1994; Bata-Csorgo et al, 1995). Transgenic mice with suprabasal
expression of integrins have shown features reminiscent of chronic
plaque psoriasis, suggesting that the relationship between hyper-
proliferation and suprabasal β1 integrin expression could be causal
(Carroll et al, 1995). Nevertheless, the functional state of these β1
integrins has not been formally addressed.
Our immunohistochemical studies with MoAb that recognize
activated β1 integrins indicate that, although there is suprabasal
expression of β1 integrins in psoriasis, these molecules seem to be in
an inactive state. Moreover, most β1 integrins in lateral and apical
surfaces of basal keratinocytes are also in a nonactive conformation,
implying a decrease of activity compared with normal skin, in which
active β1 integrins are distributed all over the basal keratinocytes. Our
results with cultured NHK, showing intense β1 fluorescence on cell–
cell contacts and the apical surface of keratinocytes but unrelated to
the expression of HUTS-21 or MG5A7, suggest a similar pattern of
expression to that found in psoriatic skin. Probably, the psoriatic-like
behavior of NHK in culture could explain the discrepancy in the
staining patterns.
It has been proposed that the presence of integrins in the differentiat-
ing cell layers stimulates proliferation in the basal layer, perhaps by
signaling that there is a deficit in the size of the differentiated
compartment that should be replenished through increased proliferation
(Carroll et al, 1995). Our results show that the expression of β1 is not
correlated with its functional state, thus indicating that downregulation
of the β1 functional activity occurs in psoriasis. Suprabasal expression
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Figure 5. Downregulation of b1 integrin activity in psoriasis, compared with normal skin. Immunohistochemical study of the expression in normal skin
(a, b) and psoriasis (d, e) of HUTS-21. Anti-CD44 (HP2/9) MoAb, used as staining control, showed a similar intensity on both normal (c) and psoriatic (f) skin.
Scale bar: (a, b, d, e) 20 µm; (c, f) 50 µm.
of inactive β1 might be related to the hyperproliferative state of
keratinocytes. β1 integrins mediate keratinocyte adhesion to extra-
cellular matrix components (Watt and Hertle, 1994), and its down-
regulation may be one of the first steps in the differentiation process
that leads keratinocytes to the spinous layer (Adams and Watt, 1990).
The mechanisms leading to the elimination of β1 from the membrane
(Dalton et al, 1995; Hotchin et al, 1995) could not be so efficient to
destroy the protein in the short time it takes keratinocytes to migrate
from the basal to the suprabasal layers. Expression of β1 integrins in
lateral and apical surfaces of NHK in culture and in skin biopsies have
suggested its implication in cell–cell interactions (Carter et al, 1990;
Larjava et al, 1990; Watt and Hertle, 1994). Although studies in
cultured NHK with other anti-β1 activation reporter MoAb (Kim and
Yamada, 1997) has shown that β1 integrins in cell–cell contact are not
in the ligand-occupied conformation, as we found with HUTS 21 and
MG5A7, our results in normal skin imply that these integrins are, at
least partially, in an activated state. A decrease of activation epitopes
expression in psoriasis, a disease of keratinocyte hyperproliferation,
suggests that activated β1 integrins on lateral and apical surfaces of the
cell might be signalling inhibition of proliferation.
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